+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuralgia Treatment Market by Treatment Type, Delivery Mode, End User, Distribution Channel, Indication, Drug Class - Global Forecast to 2030- Product Image
Neuralgia Treatment Market by Treatment Type, Delivery Mode, End User, Distribution Channel, Indication, Drug Class - Global Forecast to 2030- Product Image
Sale

Neuralgia Treatment Market by Treatment Type, Delivery Mode, End User, Distribution Channel, Indication, Drug Class - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146088
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neuralgia Treatment Market is experiencing robust expansion, with projections indicating growth from USD 1.20 billion in 2024 to USD 2.42 billion by 2030.

This burgeoning market is driven by significant advancements and an increasing demand for effective solutions, offering substantial opportunities for stakeholders engaged in healthcare innovation.

Setting the Stage for Neuralgia Treatment Innovation

Neuralgia, marked by intense nerve pain, is a critical challenge for healthcare systems globally. Patients often face intricate treatment journeys that integrate physical therapy, nerve modulation, and advanced pharmacological regimens. As technological progress, evolving regulations, and patient expectations converge, the landscape of neuralgia care is being transformed.

For stakeholders, understanding the broad spectrum of therapeutic options is crucial for enhancing patient outcomes and adding value. Advances in neuromodulation devices and targeted pharmaceutical therapies have broadened the tools available to healthcare providers, while non-pharmacological methods like acupuncture and physical therapy are gaining recognition. The shift towards patient-centric care further emphasizes the importance of customizing treatments to individual patient needs.

Emerging Trends Reshaping Neuralgia Care

The neuralgia treatment ecosystem is undergoing significant change, spurred by clinical, technological, and economic factors. Medical device innovations have expanded neuromodulation from niche usage to prominent therapy, providing precision pain relief through spinal and peripheral nerve stimulators. Meanwhile, drug delivery advancements have improved analgesic administration, optimizing therapeutic levels with reduced side effects.

Regulatory developments, like expedited review processes, encourage manufacturers to fast-track development and invest in clinical trials. The digital transformation of healthcare introduces telemedicine and remote monitoring tools that improve adherence to treatments. These trends enhance integrated care models that combine pharmacology with non-drug therapies, thus aligning with value-based care models. Such collaborations foster a dynamic and competitive market, offering decision-makers pathways to strategic planning and competitive advantage.

Decoding Market Segments for Targeted Strategies

To unlock the potential of the neuralgia treatment market, a nuanced understanding of its segments is essential. Treatment options include non-pharmacological solutions like acupuncture and neuromodulation, and pharmacological solutions featuring innovative drugs. Various delivery modes, such as injectable, oral, topical, and transdermal, cater to different patient preferences, enhancing strategic planning for market entry.

This array of options extends across different end-user settings, from ambulatory surgical centers to home healthcare, and varies by region and type of neuralgia, like diabetic neuropathy or trigeminal neuralgia. Such a comprehensive understanding aids in aligning product development and marketing strategies with the specific needs of each segment, facilitating competitive differentiation and identifying growth opportunities.

Regional Dynamics Driving Neuralgia Treatment Adoption

Diverse regional dynamics influence the market's competitive landscape. In the Americas, advanced healthcare infrastructure and favorable reimbursement policies drive rapid adoption of new therapies. In contrast, healthcare delivery variability in Europe, the Middle East, and Africa offers both opportunities and challenges, particularly in emerging markets.

In the Asia-Pacific region, urbanization and awareness of chronic pain are accelerating market growth. By tailoring market strategies to these regional dynamics, companies can facilitate risk mitigation and optimize entry efforts, ensuring better alignment with local regulations and healthcare needs.

Assessing the Ripple Effect of 2025 U.S. Tariffs

The 2025 U.S. tariffs have impacted the neuralgia treatment market by increasing costs for raw materials and pharmaceutical ingredients. Manufacturers have responded by adopting dual sourcing and local production to alleviate financial pressures. These tariffs also affect pricing strategies and reimbursement discussions with payers, prompting companies to adapt by optimizing production processes.

Despite these challenges, the market remains resilient, using tariff pressures to spur mergers and acquisitions and investments in alternative materials. This agility ensures that the industry continues to evolve, enhancing supply chain resilience and collaborative partnerships for a more sustainable market environment.

Concluding Perspectives on Neuralgia Treatment Trajectory

The neuralgia treatment market is poised for significant transformation driven by technological advancements, regulatory changes, and shifting patient expectations. The integration of neuromodulation with drug delivery systems exemplifies the innovation pushing the boundaries of therapy. Though challenges like tariffs and complex reimbursement remain, they also catalyze strategic innovations and partnerships.

Successful navigation of this market will depend on stakeholders' ability to anticipate emerging trends, cultivate cross-sector collaborations, and embrace value-based care models. By adhering to strategic imperatives, organizations can harness market potential to redefine care standards for neuralgia patients and solidify their market positioning.

Key Takeaways from This Report

  • Technological advancements in neuromodulation and drug delivery offer improved treatment efficacy.
  • Healthcare digitization enhances patient adherence and facilitates timely intervention adjustments.
  • Adapting to regional market dynamics can optimize strategies for market entry and expansion.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuralgia Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non Pharmacological
8.2.1. Acupuncture
8.2.2. Neuromodulation
8.2.3. Physical Therapy
8.3. Pharmacological
9. Neuralgia Treatment Market, by Delivery Mode
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
9.5. Transdermal
10. Neuralgia Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Healthcare
10.4. Hospitals
10.5. Specialty Clinics
11. Neuralgia Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Neuralgia Treatment Market, by Indication
12.1. Introduction
12.2. Chemotherapy Induced Neuralgia
12.3. Diabetic Neuropathy
12.4. Postherpetic Neuralgia
12.5. Trigeminal Neuralgia
13. Neuralgia Treatment Market, by Drug Class
13.1. Introduction
13.2. Anticonvulsants
13.3. Antidepressants
13.4. Local Anesthetics
13.5. NSAIDs
13.6. Opioids
13.7. Topical Agents
14. Americas Neuralgia Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Neuralgia Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Neuralgia Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Eli Lilly and Company
17.3.3. Novartis AG
17.3.4. Sanofi S.A.
17.3.5. Johnson & Johnson
17.3.6. GlaxoSmithKline plc
17.3.7. AbbVie Inc.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Grünenthal GmbH
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NEURALGIA TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. NEURALGIA TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. NEURALGIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEURALGIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY CHEMOTHERAPY INDUCED NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 57. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 58. CANADA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 100. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 107. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 108. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 119. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ITALY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 121. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 122. ITALY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 128. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 156. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. QATAR NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 170. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 171. QATAR NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 177. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 178. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 198. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 199. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 202. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 205. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 206. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 219. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 220. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 224. POLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 226. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 227. POLAND NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. POLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 246. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 248. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 249. CHINA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. INDIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 255. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 256. INDIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 262. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 263. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 266. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 290. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 294. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 301. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 315. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 322. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 329. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 330. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
TABLE 331. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neuralgia Treatment market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Grünenthal GmbH
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.42 Billion
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Neuralgia Treatment Market Report 2025 - Product Image

Neuralgia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Trigeminal Neuralgia Treatment Global Market Report 2025 - Product Image

Trigeminal Neuralgia Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Neuralgia Drug Market

Neuralgia is a type of chronic pain that affects the nerves of the central nervous system. It is often caused by nerve damage or irritation, and can be difficult to treat. Neuralgia drugs are used to reduce the pain associated with this condition. These drugs work by blocking the transmission of pain signals from the affected nerves to the brain. Commonly used neuralgia drugs include anticonvulsants, antidepressants, and opioids. These drugs can be taken orally, injected, or applied topically. The neuralgia drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to improve the quality of life for those suffering from neuralgia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.